nach oben

Social Psychiatry and Psychiatric Epidemiology

Erschienen in:

01.04.2011 | Original Paper

Mental health service use and treatment adequacy for anxiety disorders in Canada

verfasst von: Pasquale Roberge, Louise Fournier, Arnaud Duhoux, Cat Tuong Nguyen, Mirrian Smolders

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

This study examined mental health service use, minimal standards of treatment adequacy and correlates of service use and treatment adequacy for anxiety disorders in Canada.

Method

Data were drawn from the Canadian Community Health Survey: Mental Health and Well-Being (CCHS 1.2, 2002). Respondents (n = 1,803) met criteria for panic disorder, agoraphobia and/or social phobia in the past 12 months. Multiple logistic regression models were used to estimate patterns of associations between respondent characteristics, service use and treatment adequacy.

Results

The prevalence of service use for mental health problems in the past 12 months was approximately 36.9% among respondents with anxiety disorders. The rates of minimal standards of treatment adequacy ranged from 36.8% among those consulting exclusively in primary care to 51.5% among those consulting exclusively in specialised mental health services, and reached 79.5% for respondents consulting healthcare professionals in both sectors of care. Correlates of treatment adequacy included age, education level, marital status, urbanicity medical insurance, acceptability of care, comorbid mental disorders and limitations of activities.

Conclusion

These findings emphasize the need to improve the access to mental health services and the quality of care for individuals with anxiety disorders in primary care.

Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, Ballenger JC, Fyer AJ (1999) The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 60:427–435PubMedCrossRef

Lepine JP (2002) The epidemiology of anxiety disorders: prevalence and societal costs. J Clin Psychiatry 63(Suppl 14):4–8

DuPont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ (1996) Economic costs of anxiety disorders. Anxiety 2:167–172PubMedCrossRef

Issakidis C, Andrews G (2002) Service utilisation for anxiety in an Australian community sample. Soc Psychiatry Psychiatr Epidemiol 37:153–163PubMedCrossRef

Lesage A, Vasiliadis HM, Gagne MA, Dudgeon S, Kasman N, Hay C (2006) Prévalence de la maladie mentale et utilisation des services connexes au Canada: une analyse des données de l’Enquête sur la santé dans les collectivités canadiennes. Canadian Collaborative Mental Health Initiative, Mississauga (ON)

Roy-Byrne PP, Wagner AW, Schraufnagel TJ (2005) Understanding and treating panic disorder in the primary care setting. J Clin Psychiatry 66(Suppl 4):16–22

Canadian Psychiatric Association (2006) Clinical practice guidelines: management of anxiety disorders. Can J Psychiatry 51:1S–97S

Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, Haro JM, Karam EG, Kessler RC, Kovess V, Lane MC, Lee S, Levinson D, Ono Y, Petukhova M, Posada-Villa J, Seedat S, Wells JE (2007) Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 370:841–850PubMedCrossRef

Fernandez A, Haro JM, Martinez-Alonso M, Demyttenaere K, Brugha TS, Autonell J, de Girolamo G, Bernert S, Lepine JP, Alonso J (2007) Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry 190:172–173PubMedCrossRef

10.

Fernandez A, Haro JM, Codony M, Vilagut G, Martinez-Alonso M, Autonell J, Salvador-Carulla L, Ayuso-Mateos JL, Fullana MA, Alonso J (2006) Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in Spain. J Affect Disord 96:9–20PubMedCrossRef

11.

Stein MB, Sherbourne CD, Craske MG, Means-Christensen A, Bystritsky A, Katon W, Sullivan G, Roy-Byrne PP (2004) Quality of care for primary care patients with anxiety disorders. Am J Psychiatry 161:2230–2237PubMedCrossRef

12.

Wang PS, Berglund P, Kessler RC (2000) Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med 15:284–292PubMedCrossRef

13.

Wang PS, Demler O, Kessler RC (2002) Adequacy of treatment for serious mental illness in the United States. Am J Public Health 92:92–98PubMedCrossRef

14.

Young AS, Klap R, Sherbourne CD, Wells KB (2001) The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 58:55–61PubMedCrossRef

15.

Gravel R, Beland Y (2005) The Canadian Community Health Survey: mental health and well-being. Can J Psychiatry 50:573–579PubMed

16.

Kessler RC, Ustun TB (2004) The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatric Res 13:93–121CrossRef

17.

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th ed) American Psychiatric Association, Washington, DC

18.

Roberge P, Marchand A, Reinharz D, Savard P (2008) Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysis. Behav Modif 32:333–351PubMedCrossRef

19.

Goodwin R, Andersen RM (2002) Use of the behavioral model of health care use to identify correlates of use of treatment for panic attacks in the community. Soc Psychiatry Psychiatr Epidemiol 37:212–219PubMedCrossRef

20.

Westat (2003) WesVar 4.2 user’s guide. Westat, Rockville (MD)

21.

Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005) Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:629–640PubMedCrossRef

22.

Duhoux A, Fournier L, Nguyen CT, Roberge P, Beveridge R (2009) Guideline concordance of treatment for depressive disorders in Canada. Soc Psychiatry Psychiatr Epidemiol 44:385–392PubMedCrossRef

23.

Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, Polidori G, Kikkawa T, Kawakami N, Ono Y, Takeshima T, Uda H, Karam EG, Fayyad JA, Karam AN, Mneimneh ZN, Medina-Mora ME, Borges G, Lara C, de Graaf R, Ormel J, Gureje O, Shen Y, Huang Y, Zhang M, Alonso J, Haro JM, Vilagut G, Bromet EJ, Gluzman S, Webb C, Kessler RC, Merikangas KR, Anthony JC, Von Korff MR, Wang PS, Brugha TS, Aguilar-Gaxiola S, Lee S, Heeringa S, Pennell BE, Zaslavsky AM, Ustun TB, Chatterji S (2004) Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. J Am Med Assoc 291:2581–2590CrossRef

24.

Borowsky SJ, Rubenstein LV, Meredith LS, Camp P, Jackson-Triche M, Wells KB (2000) Who is at risk of nondetection of mental health problems in primary care? J Gen Intern Med 15:381–388PubMedCrossRef

25.

Fuller J, Edwards J, Martinez L, Edwards B, Reid K (2004) Collaboration and local networks for rural and remote primary mental healthcare in South Australia. Health Soc Care Community 12:75–84PubMedCrossRef

26.

McCabe S, Macnee CL (2002) Weaving a new safety net of mental health care in rural America: a model of integrated practice. Issues Ment Health Nurs 23:263–278PubMedCrossRef

27.

Starkes JM, Poulin CC, Kisely SR (2005) Unmet need for the treatment of depression in Atlantic Canada. Can J Psychiatry 50:580–590PubMed

28.

Heuzenroeder L, Donnelly M, Haby MM, Mihalopoulos C, Rossell R, Carter R, Andrews G, Vos T (2004) Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Aust N Z J Psychiatry 38:602–612PubMed

29.

Sareen J, Jagdeo A, Cox BJ, Clara I, ten Have M, Belik SL, de Graaf R, Stein MB (2007) Perceived barriers to mental health service utilization in the United States, Ontario, and the Netherlands. Psychiatr Serv 58:357–364PubMedCrossRef

30.

Thompson A, Hunt C, Issakidis C (2004) Why wait? Reasons for delay and prompts to seek help for mental health problems in an Australian clinical sample. Soc Psychiatry Psychiatr Epidemiol 39:810–817PubMed

31.

Jorm AF, Christensen H, Griffiths KM (2005) The impact of beyondblue: the national depression initiative on the Australian public’s recognition of depression and beliefs about treatments. Aust N Z J Psychiatry 39(4):248–254PubMed

32.

Wang PS, Angermeyer M, Borges G, Bruffaerts R, Tat CW, de GG, Fayyad J, Gureje O, Haro JM, Huang Y, Kessler RC, Kovess V, Levinson D, Nakane Y, Oakley Brown MA, Ormel JH, Posada-Villa J, Aguilar-Gaxiola S, Alonso J, Lee S, Heeringa S, Pennell BE, Chatterji S, Ustun TB (2007) Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry 6:177–185

33.

Gilbody SM, Whitty PM, Grimshaw JM, Thomas RE (2003) Improving the detection and management of depression in primary care. Qual Saf Health Care 12:149–155PubMedCrossRef

34.

Rhodes AE, Fung K (2004) Self-reported use of mental health services versus administrative records: care to recall? Int J Methods Psychiatric Res 13:165–175CrossRef

35.

Wang PS, Demler O, Olfson M, Pincus HA, Wells KB, Kessler RC (2006) Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry 163:1187–1198PubMedCrossRef

36.

Smolders M, Laurant M, Roberge P, van Balkom A, van Rijswijk E, Bower P, Grol R (2008) Knowledge transfer and improvement of primary and ambulatory care for patients with anxiety. Can J Psychiatry 53:277–293PubMed

Titel: Mental health service use and treatment adequacy for anxiety disorders in Canada
verfasst von: Pasquale Roberge
Louise Fournier
Arnaud Duhoux
Cat Tuong Nguyen
Mirrian Smolders
Publikationsdatum: 01.04.2011
Verlag: Springer-Verlag
Erschienen in: Social Psychiatry and Psychiatric Epidemiology / Ausgabe 4/2011
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-010-0186-2

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Healthcare and social services resource use and costs of self-harm patients

RETRACTED ARTICLE: Multimorbidity: not just an older person’s issue. Results from an Australian biomedical study

Self-reported depression in first-year nursing students in relation to socio-demographic and educational factors: a nationwide cross-sectional study in Sweden

Public knowledge, beliefs and attitudes towards patients with schizophrenia: Buenos Aires